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Unsupervised data clustering has found extensive applications in various data stratification, pattern categorization, and knowledge discovery tasks beyond existing knowledge (1) . An outstanding problem is the clustering of big data beyond conventional similarity-based approaches (2) (3) (4) (5) . Specifically, unsupervised clustering of bioactive molecules with respect to their common molecular determinants(6-10) facilitates the mapping of bioactive or pharmacological chemical space, the investigation of structureactivity relationships, and drug discovery (10, 11) . Several similarity-based methods have been employed for unsupervised grouping of molecules by hierarchical clustering of the molecular scaffolds (6) and substructure fingerprints (9) , and by matching molecular fragments (7, 12) , substructures (8, 12) and physicochemical properties (10) . These methods employ the similarity principle for clustering molecules under the conventional molecular representations (molecular scaffolds, fragments, substructure fingerprints, and physicochemical properties). However, not all complex features of bioactivities are capturable by similarity-based analysis within conventional molecular frameworks. A new approach is needed for clustering molecules and other big data beyond the conventional algorithms and data representations.
A potentially-useful approach for unsupervised clustering beyond the conventional algorithms and representations is deep neural networks (DNNs). DNNs have been employed for unsupervised learning of the informative features by its unique ability to flatter the complex data (13) and segment them into classes of specific characteristics(14) while preserving the local and global data characteristics (15) . The DNN-learned informative features have been used as pre-trained representation features of the conventional machine learning methods for improved data clustering (16) and classification (17) . DNNs trained on 4.9-50 million samples have successfully accomplished difficult tasks (18, 19) . These distinguished capabilities of DNNs in learning complex features from big data may be explored for unsupervised clustering of big data beyond the conventional frameworks.
DNN-learned informative features has been presented or projected to 2-dimensional latent space for revealing the data landscapes in that space (20) (21) (22) . In some cases, the DNN-learned features in the 2-dimensional latent space present a landscape of band-clusters (data distributed into bands of particle streams), with each band-cluster grouping together subsets of the data of common frameworks but varying global features (e.g. images of a handwritten digit, Reuter newswire stories of a topic such as energy markets, and drug-like molecules of similar logP values) (20, 21, 23) .
Hence, DNNs may have the ability to group data into band-clusters of common frameworks beyond similarity and conventional data representations. A question is whether this ability may be exploited for unsupervised clustering of structurally-diverse bioactive molecules into band-clusters of molecules of selected bioactivities with unique elements of pharmacophores (24) , privileged substructures (25) (26) (27) , and scaffold branches (11) . Although the band-cluster characteristics are contained in the DNN-learned features, feeding these features into a conventional clustering method(16) subject them to the limitations of the similarity framework. Projection of the DNN-learned features to 2-dimentional space (20) (21) (22) lead to information loss in low-dimensionality and in some cases subject to the limitations of the dimensionality-reduction methods (e.g. PCA and t-SNE).
One alternative approach to alleviate these problems is to employ DNNs to directly learn informative features in a 3-dimentional latent space, wherein the DNN-generated band-clusters are subject to less information-loss than in 2-dimensional latent space, and the landscapes can be straightforwardly displayed and analyzed by a space-navigation simulation software without using a dimensionalityreduction method. A critical question is whether the DNN-learned features in 3-dimentional latent space can adequately indicate the band-clusters of common frameworks. This question was interrogated by analyzing the members of individual band-cluster with respect to their bioactivity-classes (e.g. kinase inhibitors) and the common sub-structural features with respect to the literature-reported pharmacophores(28) and privileged substructures (25, 26) of the bioactivity classes in the band-cluster.
We developed the deep autoencoders (DAEs) for unsupervised clustering of 1.39 million ChEMBL bioactive molecules (29) in a 3-dimensional latent chemical space, together with a chemical space navigation simulation software DeepChemScape for displaying and analyzing the band-cluster landscapes. The molecules of individual band-cluster were extracted by density analysis or by reference to the manuallyselected molecules that visibly define band-cluster boundaries. The intra-cluster molecules of two selected band-clusters were analyzed for their bioactivity profiles and common sub-structural features in comparison with the literature-reported pharmacophores (28) and privileged structures (25, 26) of the bioactivities enriched in these band-clusters.
Data collection, processing and molecular representation
The SMILES structures, macromolecule targets and the activity values (in IC50, EC50, and Ki) of 1.7 million bioactive molecules were from the ChEMBL database version-22 (29) . The SMILES structures were processed by using Open Babel (30) to convert them into the MOL 2D format, remove single-atom structures and salts, discard the smaller independent structures, and add explicit hydrogens. There are 386,655 molecules active against 2,245 targets with IC50, EC50, or Ki <10 μM, a widely-used bioactivity cut-off(31). These 2,245 targets were mapped to 30 level-2 ChEMBL target families(29) (Supplementary Table S1 ), 1,398 Pfam domain families, or 2,251 Interpro domain families via CheMBL crosslinks to the corresponding Uniprot and Interpro entries. There are 1,011,600 additional molecules with lower activities (IC50, EC50, or Ki >10 μM), ambiguous activity values (e.g. % inhibition at one concentration), or un-defined targets (e.g. cell-lines). These molecules of low or unspecified activities were used for training the DAE models.
In chemical space mapping (11) , visualization(32) and virtual screening (33) , molecules have been frequently represented by molecular fingerprints(9, 33) that encode molecular structures by a series of binary digits indicating the presence or absence of individual substructures (9, 33) . Specifically, we used Padel(34) to compute the 881-bit Pubchem fingerprints for 1,623,663 molecules. These molecules were further divided into two sets: Version-19 set (1,398,255 molecules) and the new-additions set (225,408 molecules added after Version 19) for training and validating the DAE models.
Unsupervised clustering and display of molecules in a 3-dimensional latent chemical space with deep autoencoder networks
Our DAEs are composed of a pair of complementary DNNs. An auto-encoder converts molecular fingerprints into 3-imensional latent codes for data clustering. An auto-decoder converts the latent codes back to the original molecular fingerprints for optimizing the auto-encoder. The auto-encoder was trained and tested on 4/5 and 1/5 randomly selected molecules of the Version-19 set, and validated on the new-additions set. The optimization of the DAE hyperparameters was conducted in two phases as described in Supplementary Methods, which proceeds until the reconstruction rate reaches optimal value and the molecules are distributed in band-clusters (20, 21, 35) Table S4 ), only six molecular scaffolds were found in both band-clusters (indoles, benzenoids, biphenyls, indolines, amino acids and pyrimidines).
Relevance and distinction of DAE-captured sub-structural features with respect to the literaturereported pharmacophores and privileged structures.
A question may be raised about the relevance of the DAE-captured sub-structural features to the selected bioactivities of the band-cluster. This question was probed by comparing the sub-structural features of band-cluster A (8.66% members are kinase inhibitors) with the literature-reported pharmacophores and privileged structures of kinase inhibitors (26, 28, 36) , and the sub-structural features of band-cluster B (15.95% members are GPCR ligands) with the literature-reported privileged structures of GPCR ligands (37) . Some sub-structural features of band-cluster A form the key frameworks of the literature- Figure S4) . These are the combinations of a core hydrogen-bond element (V-shaped NCO, NCN, NCCO) and a core hydrophobic ring element (R and RN).
The connection of the DAE-captured sub-structural features to the frameworks of the selected bioactivities and the concentration of molecules of these bioactivities in a band-cluster is consistent with the reports that the kinase privileged fragments provide ~5-fold enrichment in kinase inhibitors (26) . It is also consistent with the reports that some privileged molecular scaffolds enable activities against multiple target classes( 25, 38) . Nonetheless, the DAE-captured sub-structural elements differ from the literaturereported pharmacophores and privileged fragments in one aspect. DAEs capture the fundamental substructural elements and their structural variations whose combinations define the frameworks of the pharmacophores or privileged fragments. In contrast, the literature-reported kinase privileged structures are specific fragments such as the bisaryl-NH-linker fragments (26) and the bisphenylether scaffolds (38) . Therefore, by learning the fundamental elements of structural frameworks, DAEs capture more variety of pharmacophores and privileged structures within individual band-cluster.
Intra band-cluster distribution of bioactivity targets
Given the banding of molecules of the selected bioactivity classes into selected band-clusters, a question arises about whether the molecules of specific target are further banded into selected sub-regions within a band-cluster. We analyzed the targets of the kinase inhibitors in band-cluster A (Supplementary Table   S2 ) and the targets of the GPCR ligands in band-cluster B (Supplementary Table S3 ). While the molecules of the same target may be across multiple sub-regions, they tend to be banded in 1-3 selected subregions. In band-cluster A, the nine sub-regions populated by kinase inhibitors (Figure 2 ) are labeled as A1 to A9 from nearer the center of bioactive universe to the outward direction along the band-cluster. In The molecular scaffolds in sub-cluster A are also banded. A1 is enriched with N-phenylthioureas (8 molecules). A2 is populated by diazines, pyrimidines, diazanaphthalenes, thienopyrimidines, quinazolinamines, and benzodiazines (14, 14, 12, 12, 12 and 12 molecules). A3 is populated by benzimidazoles, diazanaphthalenes, benzodiazines, imidazopyridines and pyrimidines (11, 8, 8, 6 , and 6 molecules). A6
is enriched with benzazepines and indoles (7 and 4 molecules). A7 is enriched with benzenoids, Nphenylureas and indolines (6, 5, and 3 molecules). A8 is populated by indoles, indolines, amino acids, pyrroles, carbazoles, pyrrolopyridines, and pyrrolocarbazoles (72, 34, 28, 24, 19, 15 and 13 molecules).
A9 is populated by pyrrolocarbazoles, carbazoles, indolocarbazoles, and indoles (10 molecules each). A similar pattern of banded distribution of the molecular scaffolds were also found in band-cluster B.
Concluding remarks
DAEs showed superior capability in unsupervised clustering of big data into band-clusters of unique DAEs further band the molecules in a band-cluster into selected sub-regions enriched with higher concentration of the same bioactivity target and distinguished sets of molecular scaffolds.
These distinguished features of DAE-derived band-clusters are useful for grouping big data into functionally or architecturally relevant groups (clusters) and sub-groups (sun-regions). Our method may find extensive applications in big data clustering, stratification and knowledge discovery tasks in drug discovery(2), healthcare(3), biomedicine(4), biology(5), astronomy(39), economics(40) and other fields.
Our method is based on the deep feature learning in a 3-dimensional latent space followed by visualization-facilitated analysis of data band-clusters. Although DAEs are capable of clustering big data into functionally and architecturally relevant groups and sub-groups, the learning in a 3-dimensioanl latent space instead of the usual higher dimensional latent space likely results in some degree of information loss, which may affect the quality and purity of the band-clusters and their sub-regions, as indicated by the scattered distribution of molecules of various bioactivity classes in individual band-clusters. Further efforts are needed for the development of bind-cluster extraction and evaluation methods in higherdimensional latent space.
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